910 abstracts found.



Results filter

Integration of HER-2 result into breast multi-disciplinary decision making: results of a UK audit

Year:

Session type:

Louise Li, Mark Verrill

Northern Centre for Cancer Treatment, Newcastle Upon Tyne, UK


Suicide rates in US cancer patients

Year:

Session type:

Stephanie Misono1,2, Noel S Weiss2,3, Jesse R Fann2,3, Mary Redman3, Bevan Yueh1, 2,3

1VA Puget Sound Health Care System, Seattle, USA, 2University of Washington, Seattle, USA, 3Fred Hutchinson Cancer Research Center, Seattle, USA


Use of nanomagnets to enhance monocyte delivery of gene therapy to tumours

Year:

Session type:

Munitta Muthana1, Simon Scott2, Craig Murdoch1, Neil Farrow3, Jon Dobson3, Claire Lewis1

1University of Sheffield, Sheffield, UK, 2University of Kent, Kent, UK, 3Keele University School of Medicine, Stoke on Trent, UK


Improving ethnic data collection for cancer

Year:

Session type:

Janet Dunn

Warwick Medical School, University of Warwick, UK


ERK-MAP kinase signalling: biological context, cellular location, signal strength and duration dictate cell fate

Year:

Session type:

John Blenis

Harvard Medical School, Boston, USA


MR Imaging in breast cancer – results of the COMICE trial

Year:

Session type:

Lindsay Turnbull2, Ian Harvey2, Sarah Brown1, Andy Hanby3, Phil Drew4, Catherine Olivier1, Vicky Napp1, Julia Brown1

1Clinical Trials Research Unit, University of Leeds, Leeds, UK, 2Centre for MR Investigations, Hull Royal Infirmary, Hull, UK, 3St James's University Hospital, Leeds, UK, 4University of Hull, Hull, UK


The experiential landscape of terminal illness

Year:

Session type:

Harvey Chochinov

University of Manitoba and Manitoba Palliative Care Research Unit, Canada


Immunological targeting of the cancer phosphoproteome

Year:

Session type:

Mark Cobbold2, Andrew Norris4, Fiyas Mohammed1, Joy M. Polefrome4, Jie Qian4, Andrea M. De Santis4, Angela L. Zarling3, Jefferey Shabanowitz4, Benjamin E. Willcox1, Michael E. Williams5, Donald F. Hunt4, Victor H. Engelhard3

1CR-UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK, 2Department of Clinical Immunology, University of Birmingham, Birmingham, UK, 3Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, USA, 4Department of Chemistry, University of Virginia, Charlottesville, VA, USA, 5Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA


Title to be confirmed

Year:

Session type:

Tariq White

University of Leeds, UK


C-Met oncogenic mutants sustain signals in the endosome and are protected against downregulation

Year:

Session type:

Carine Joffre, Stephanie Kermorgant

Institute of Cancer and Cancer Research UK Clinical Centre, Bart's and The London School of Medicine and Dentistry, London, UK


Page 91 of 91« First...25...91